Importantly, our results showed that SERPINE1 silencing suppressed the CFC production of CD34+ cells from CML patients, including the quiescent subset, which expanded the previous findings. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.